Prelude Therapeutics Inc

Explore how Prelude Therapeutics is pioneering oral small‑molecule cancer treatments, boosting investor interest despite current R&D focus and a negative P/E ratio.

Prelude Therapeutics Inc is a pioneering biopharmaceutical company that is pushing the boundaries of cancer treatment with its innovative, orally bioavailable, and small molecule therapies.